EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reply to Zhou and Tsao: Synergy rarely underlies the benefits of combination cancer therapy

Nicole A Traphagen Ho, Myles Brown iD

Proceedings of the National Academy of Sciences · 10.11.2026 · 123 (45)

DOI: 10.1073/pnas.2618841123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.10.2026. Verfasst von Nicole A Traphagen Ho und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | NIH | NCI | Center for Cancer Research (CCR).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215.

ORCID-Profile: Myles Brown

Förderung

  • NCI NIH HHS
  • HHS | NIH | NCI | Center for Cancer Research (CCR)

Zitieren

APA

Traphagen Ho, N. A., & Brown, M. (2026). Reply to Zhou and Tsao: Synergy rarely underlies the benefits of combination cancer therapy. Proceedings of the National Academy of Sciences, 123(45). https://doi.org/10.1073/pnas.2618841123

Vancouver

Traphagen Ho NA, Brown M. Reply to Zhou and Tsao: Synergy rarely underlies the benefits of combination cancer therapy. Proceedings of the National Academy of Sciences. 2026;123(45). doi:10.1073/pnas.2618841123

BibTeX
@article{TraphagenHo2026,
  author = {Traphagen Ho, Nicole A and Brown, Myles},
  title = {Reply to Zhou and Tsao: Synergy rarely underlies the benefits of combination cancer therapy},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {45},
  doi = {10.1073/pnas.2618841123}
}
Kostenlos starten →